铁线虫

专利出海交易爆发中国创新药成为“全球合伙人”,专利出海交易爆发中国创新药成为“全球合伙人”_我的网站

步步惊心：丽

A | Pushpa star Allu Arjun recently took to social media to express his admiration for Aditya Dhar's Dhurandhar. The spy-thriller stars Ranveer Singh, Arjun Rampal, Akshaye Khanna, Sanjay Dutt, Sara Arjun, R Madhavan and Rakesh Bedi among others. The actor took to X (formerly Twitter) to write, "Just watched #Dhurandhar. A brilliantly made film filled with fine performances, the finest technical aspects, and amazing soundtracks." Praising the cast for their performance, Allu Arjun continued, "Magnetic presence by my brother @RanveerOfficial, he rocked the show with his versatility. Charismatic aura by #AkshayeKhanna ji, and the rock-solid presence of @duttsanjay ji, @ActorMadhavan garu, @rampalarjun garu, and all the other artists. Sweet presence by #SaraArjun as well. Congratulations to the entire team - all the technicians, cast, crew, #JyotiDeshpande ji, and @jiostudios Anddddd… of course, the captain of the ship, the brilliant and spectacular filmmaker @AdityaDharFilms garu. You nailed it as an ace filmmaker with full swag. I loved it! Just watch it and enjoy the show, guysss…" Take a look at his post: Just watched #Dhurandhar. A brilliantly made film filled with fine performances, the finest technical aspects, and amazing soundtracks.Magnetic presence by my brother @RanveerOfficial, he rocked the show with his versatility.Charismatic aura by #AkshayeKhanna ji, and the… — Allu Arjun (@alluarjun) December 12, 2025 Dhurandhar has been receiving a lot of praises from the industry folks. Karan Johar called it his favourite performance of Ranveer Singh. Vicky Kaushal, too, praised the film. Meanwhile, Hrithik Roshan said that he did not agree with the politics of the film, but praised the storytelling and the performance of the cast. Brooklyn Nine Nine star Terry Crews also gave a shoutout to the film. In Dhurandhar, Ranveer Singh plays Hamza, an Indian spy sent to Pakistan to infiltrate a terror network. Set against the backdrop of the IC-814 hijacking in 1999 and the 2001 Indian Parliament attack, the film follows Ajay Sanyal, the Intelligence Bureau Chief as he assigns Hamza a high-risk mission to dismantle the group operating across the border. Also Read: DOP Vikash Nowlakha Reveals How Aditya Dhar and He Built The Look of Dhurandhar。

B | 　　央广网北京8月26日消息(记者夏青)据中央广播电视总台经济之声报道，国内创新药审批又有新进展。8月17日至23日，共有34款1类创新药首次在中国获批临床试验默示许可。还有一组更亮眼的数据：今年上半年，中国创新药对外授权共达成81笔合作，交易总额约1100亿美元，已经达到2025年全年总额的80%，再创历史同期新高。

C | 　　业内专家表示，这背后更重要的是中国创新药企角色的根本性转变。从过去的“原料供应商”，升级为与跨国药企平等对话、利益共享的“全球合伙人”。　　上半年科创板创新药企业绩亮眼　　创新药因研发难度大、附加值高，被誉为医药产业“皇冠上的明珠”。2026年上半年，科创板创新药企交出了漂亮“成绩单”。　　诺诚健华报告显示，上半年营收同比增长55.5%，达到11.4亿元，净利润2.4亿元，同比扭亏为盈。泽璟制药也交出上市以来首份盈利半年报，百济神州则交出史上最优半年度成绩单。　　“科创板创新药企业已经开始进入盈利兑现期。”苏商银行特约研究员武泽伟分析，“当前，创新药行业的商业化能力修复，海外权益合作持续落地，有效补充企业的运营现金流。国内审评与支付机制不断优化，缩短新药的上市周期，拓宽产品收入边界。依托完整的产业链红利，国内的生物医药配套体系日趋成熟，研发服务企业持续承接海内外订单，充分分享全球研发投入回暖带来的业务增量。”　　中国创新药对外授权交易额迭创新高　　中国创新药获得全球市场的认可。2025年全年，中国药企的对外授权潜在交易总金额高达1356.55亿美元，是2024年的两倍多，一举登顶全球首位。今年上半年，中国创新药对外授权交易总额约1100亿美元，达到了去年全年总额的八成，再创历史新高。　　国家药监局药品注册管理司副司长蓝恭涛介绍，中国在研新药数量约占全球30%，位列全球第二。中国医药产业创新效率居世界前列。　　蓝恭涛说：“2025年我国批准的11个新靶点、新机制药品中，4个是国产创新药，占比不到一半。今年上半年，我国批准的11个新靶点、新机制药品全都是自主研发的国产创新药。”　　中国药企正从“跟跑者”转变为“合作者”　　中国创新药实现了从“卖产品”到“卖技术”的跨越，中国创新药企业正在以“全球合作伙伴”的身份，与跨国药企联合开发、共享收益。　　武泽伟说：“未来，行业会逐步脱离同质化跟随研发，转向全新靶点与全新机制的源头创新。出海模式也从早期对外授权，过渡到自主完成海外申报与全球商业化运营。产业从产品出海升级为技术平台与研发体系的对外输出，整体国际竞争力稳步增强。”　　国家医保局近日发布《全民医疗保障“十五五”规划》，明确支持创新药纳入医保、推动商保创新药目录，释放强烈利好信号。　　中国医药创新促进会首席专家宋瑞霖说：“中国的创新药现在正处在一个历史性的崛起阶段，我们经历了从‘跟跑’到‘并跑’，现在我们正处于部分领域‘领跑’的阶段。